Anti‐gp210 and anti‐centromere antibodies for the prediction of PBC patients with an incomplete biochemical response to UDCA and bezafibrate

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|45|8|827-828

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.45, Iss.8, 2015-08, pp. : 827-828

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti‐centromere antibody‐positive Sjögren's syndrome: A distinct clinical subgroup?

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 7, 2015-09 ,pp. : 776-782

John Wiley & Sons Inc

Access to resources Recommend Favorite

IMMUNE COMPLEXES IN THE SERA OF PATIENTS WITH ANTI‐RNP ANTIBODIES

By  

THE JOURNAL OF DERMATOLOGY, Vol. 8, Iss. 1, 1981-02 ,pp. : 21-26

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: restoring therapeutic infliximab drug levels in patients with loss of response—pharmacokinetics and anti‐drug antibodies as useful guidance tools

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 6, 2018-03 ,pp. : 845-846

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neutralizing anti‐interferon‐α antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (α2a) and lymphoblastoid interferon‐α

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 1996-08 ,pp. : 300-305

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neutralizing anti‐interferon‐α antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (α2a) and lymphoblastoid interferon‐α

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 1996-08 ,pp. : 300-305

John Wiley & Sons Inc

Access to resources Recommend Favorite